Synthesis Capital (Boston) Overview

  • Investor Type
  • Venture Capital

  • Status
  • Inactive

  • Investments
  • 27

  • Exits
  • 24

Exits

Synthesis Capital (Boston) General Information

Company Description

Founded in 2007, Synthesis Capital was a venture capital firm based in Boston, Massachusetts. The firm sought to invest in the life science, healthcare, biotechnology, biopharmaceutical, medical devices, medical technology, healthcare services, and novel drug development industries.

Business Details

Formerly Known As
Advent Healthcare Ventures
Year Founded
2007
Investor Status
Out of Business
Primary Investor Type
Venture Capital
Corporate Office
  • 184 High Street
  • 4th floor
  • Boston, MA 02110
  • United States

Synthesis Capital (Boston) Investments (27)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Triplebar 25-Oct-2023 Early Stage VC Discovery Tools (Healthcare) Generating Revenue
Trident Pharmaceuticals 01-Sep-2012 Biotechnology Out of Business
Prexa Pharmaceuticals 11-May-2011 Pharmaceuticals Out of Business
Horizon Pharmaceutical 01-Jan-2011 Drug Discovery Generating Revenue
Nereus Pharmaceuticals 23-Jun-2010 Drug Discovery Out of Business
Revision Therapeutics 20-Apr-2010 Drug Discovery Out of Business
Ampla Pharmaceuticals 28-Apr-2008 Pharmaceuticals Out of Business
CV Therapeutics 16-Apr-2008 Drug Discovery Generating Revenue
Sirion Therapeutics 09-Apr-2007 Early Stage VC Pharmaceuticals Out of Business
Health Hero Networks 17-Nov-2006 Later Stage VC Medical Records Systems Generating Revenue
You’re viewing 10 of 27 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synthesis Capital (Boston) Exits (24)

Company Name Exit Date Exit Type Exit Size
MedVantx 01-Jan-2024 Secondary Transaction - Private
Horizon Pharmaceutical 25-Oct-2016
Trident Pharmaceuticals 01-Nov-2015
Prexa Pharmaceuticals 01-May-2015
Incanthera Therapeutics 28-Jan-2015
Revision Therapeutics 01-Jan-2013
Nereus Pharmaceuticals 01-Dec-2012
Astex Therapeutics 20-Jul-2011
Sirion Therapeutics 08-Jun-2010 Out of Business
Decode Genetics 15-Jan-2010 Merger/Acquisition
You’re viewing 10 of 24 exits. Get the full list »

Synthesis Capital (Boston) Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Synthesis Capital (Boston) Co-Investors (6)

Name With Exits Lead Partner Series Industry
Essential Capital 1 Series chart Industry bar
Rabo Investments Series chart Industry bar
Stray Dog Capital Series chart Industry bar
The Production Board Series chart Industry bar
iSelect Fund Series chart Industry bar
You’re viewing 5 of 6 co-investors. Get the full list »

Synthesis Capital (Boston) FAQs

  • What is Synthesis Capital (Boston)?

    Founded in 2007, Synthesis Capital was a venture capital firm based in Boston, Massachusetts.

  • When was Synthesis Capital (Boston) founded?

    Synthesis Capital (Boston) was founded in 2007.

  • Where is Synthesis Capital (Boston) headquartered?

    Synthesis Capital (Boston) is headquartered in Boston, MA.

  • How many investments has Synthesis Capital (Boston) made?

    Synthesis Capital (Boston) has made 27 investments.

  • What has Synthesis Capital (Boston) invested in?

    Synthesis Capital (Boston) has made numerous investments in companies like Triplebar, Trident Pharmaceuticals, and Prexa Pharmaceuticals within the Discovery Tools (Healthcare), Biotechnology, and Pharmaceuticals industries.

  • What has Synthesis Capital (Boston) invested in recently?

    Synthesis Capital (Boston)'s latest investment was on 25-Oct-2023 in Triplebar, a company within the Discovery Tools (Healthcare) industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process